Won J. Ho

Won J. Ho

Oncology

201 North Broadway Street, Viragh BLDG 5th FL
Viragh BLDG 5th FL
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 145 publications

Quantitative calibration of a spatial QSP model identifies fibroblast impact on HCC immunotherapy.

Quantitative calibration of a spatial QSP model identifies fibroblast impact on HCC immunotherapy.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 14, 2026

Quantitative 3D histology reveals localized immune remodeling during early pancreatic cancer progression.

Quantitative 3D histology reveals localized immune remodeling during early pancreatic cancer progression.

Journal: Cell press blue

Published: June 22, 2026

Baseline and dynamic cytokines as biomarkers for immune checkpoint and anti-VEGF therapy in advanced hepatocellular carcinoma.

Baseline and dynamic cytokines as biomarkers for immune checkpoint and anti-VEGF therapy in advanced hepatocellular carcinoma.

Journal: ESMO gastrointestinal oncology

Published: April 17, 2026

Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

Journal: Nature communications

Published: April 15, 2026

Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in Pancreatic Cancer.

Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in Pancreatic Cancer.

Journal: bioRxiv : the preprint server for biology

Published: March 23, 2026

Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.

Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.

Journal: Cancer research

Published: March 19, 2026

B Cells and Tertiary Lymphoid Structures as Integral Components of the Cancer Immunity Cycle.

B Cells and Tertiary Lymphoid Structures as Integral Components of the Cancer Immunity Cycle.

Journal: Cancer immunology research

Published: March 12, 2026

Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma.

Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma.

Journal: Journal for immunotherapy of cancer

Published: February 02, 2026

First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.

First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.

Journal: Cancer discovery

Published: December 31, 2025

Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially regulate T-cell phenotype and function.

Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially regulate T-cell phenotype and function.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: December 29, 2025

Peripheral Th17 immune signature associates with excellent response to anti-PD1/anti-PD-L1 therapy across solid tumors.

Peripheral Th17 immune signature associates with excellent response to anti-PD1/anti-PD-L1 therapy across solid tumors.

Journal: Cancer immunology research

Published: December 17, 2025

Quantitative Calibration of a Spatial QSP Model Identifies Fibroblast Impact on HCC Immunotherapy.

Quantitative Calibration of a Spatial QSP Model Identifies Fibroblast Impact on HCC Immunotherapy.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Showing 1-12 of 145

Last Updated: 09/26/2026